Thus, these inhibitory molecules likely play a crucial role in immune regulation (2B4 or CD160) and inhibition (CTLA-4 or PD-1) during acute and chronic T. cruzi infection, respectively, and might serve as biomarkers for monitoring the progression of ChD. This evidence concerns the gene CD244 and coronary artery disorder.